Aarti Drugs jumps on getting GMP certificate from UK MHRA

04 Oct 2024 Evaluate

Aarti Drugs is currently trading at Rs. 525.15, up by 11.50 points or 2.24% from its previous closing of Rs. 513.65 on the BSE.

The scrip opened at Rs. 519.95 and has touched a high and low of Rs. 528.85 and Rs. 515.00 respectively. So far 14546 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 634.90 on 27-Aug-2024 and a 52 week low of Rs. 430.00 on 28-Mar-2024.

Last one week high and low of the scrip stood at Rs. 528.85 and Rs. 505.05 respectively. The current market cap of the company is Rs. 4793.04 crore.

The promoters holding in the company stood at 55.67%, while Institutions and Non-Institutions held 10.31% and 34.02% respectively.

Aarti Drugs has received ‘Certificate of GMP Compliance of a Manufacturer’ from Medicines and Healthcare products Regulatory Agency, United Kingdom (UK MHRA) for manufacturing facility of its subsidiary - (Pinnacle Life Science) located at Baddi, Himachal Pradesh. 

Aarti Drugs is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science.

Aarti Drugs Share Price

427.65 -4.25 (-0.98%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.